Chronotherapeutic drug delivery systems - an approach to circadian rhythms diseases

Current Drug Delivery

Volumn 8, Issue 6, 2011, Pages 622-633

  Sunil, S A ^a   Srikanth, M V ^a   Rao, N Sreenivasa ^a   Uhumwangho, M U ^b   Latha, K ^c   Murthy, K V Ramana ^a  

^a ANDHRA UNIVERSITY   (India)

^b UNIVERSITY OF BENIN   (Nigeria)

^c G Pulla Reddy College of Pharmacy   (India)

Author keywords

Chronopharmacokinetics; Chronotherapeutic drug delivery systems; Circadian rhythms

Indexed keywords

AMINOPHYLLINE; AMLODIPINE; ATENOLOL; BISOPROLOL; CAPTOPRIL; CARVEDILOL; CISPLATIN; CYCLOSPORIN; DIGOXIN; DILTIAZEM; ENALAPRIL; FAMOTIDINE; FLUOROURACIL; FUROSEMIDE; GLYCERYL TRINITRATE; HOKUNALIN; HYDROCHLOROTHIAZIDE; INDAPAMIDE; INNPRAN; ISOPRENALINE; ISOSORBIDE MONONITRATE; LISINOPRIL; METHOTREXATE; METOPROLOL; NADOLOL; NIFEDIPINE; ORCIPRENALINE; PEPEID; PERINDOPRIL; PROPRANOLOL; SIMVASTATIN; SOTALOL; THEOPHYLLINE; TORASEMIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERAPAMIL; ZACOR;

ARTHRITIS; ASTHMA; CANCER CHEMOTHERAPY; CARDIOVASCULAR DISEASE; CEFORM; CHRONOBIOLOGY; CHRONOTHERAPY; CIRCADIAN RHYTHM; CODAS; CONTIN; DIABETES MELLITUS; DIFFUCAPS; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; EGALET; HUMAN; HYPERTENSION; OROS; PATIENT COMPLIANCE; PRIORITY JOURNAL; PULSNICAPS; REVIEW; TIMERX; TREATMENT OUTCOME; ULCER;

ASTHMA; CARDIOVASCULAR DISEASES; CIRCADIAN RHYTHM; DRUG CHRONOTHERAPY; DRUG DELIVERY SYSTEMS; HUMANS; INFLAMMATION; NEOPLASMS; PEPTIC ULCER;

EID: 80054052138     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/156720111797635559     Document Type: Review

References (75)

1. Khan, Z.; Pillay, V.; Choonara, Y. E.; du Toit, L.C. Drug delivery technologies for chronotherapeutic applications. Pharm. Dev. Technol., 2009, 14, 602-612
2. Smolensky, M. H.; Peppas, N. A. Chronobiology drug delivery and chronotherapeutics. Adv. Drug Deliv. Rev., 2007, 59, 828-851
3. Reinberg, A.; Smolensky, M.H. Biologic Rhythms And Medicine, Cellular Metabolic, Pathophysiologic And Pharmacologic Aspects. Springer-Verlag, 1983, p. 305
4. Haus, E.; Touitou, Y. Biologic Rhythms In Clinical And Laboratory Medicine. Springer-Verlag, 1992, p.730
5. Hastings, M. H.; Reddy, A. B.; Maywood, E. S. A clock-work web circadian time in brain and periphery in health and disease. Nat. Rev. Neurosci., 2003, 4, 649-661
6. Lowrey, P. L.; Takahashi, J. S. Mammalian circadian biology: elucidating genome-wide levels of temporal organization. Annu. Rev.Genomics. Hum. Genet., 2004, 5, 407-441
7. Reppert, S.M.; Weaver, D. R. Coordination of circadian timing in mammals. Nature, 2002, 418, 935-941
8. Li, J.J. Circadian variation in myocardial ischemia the possible mechanisms involving in this phenomenon. Med. Hypotheses, 2003, 61, 240-243
9. Pittendrigh, C. S. Temporal organization: reflections of a Darwinian clock-watcher. Annu. Rev. Physiol., 1993, 55, 16-54
10. Moore Ede, M.; Fuller, C.; Sulzman, F. The Clocks That Time Us; Commonwealth fund publications, Havard University Press: Cambridge: Boston, 1982
11. Smolensky, M.H.; D'Alonzo, G.E. Biologic rhythms and medicine. Am. J. Med., 1988, 85, 34-46
12. Gherghel, D.; Hosking, S.L.; Orgul, S. Autonomic nervous system, circadian rhythms, and primary open-angle glaucoma. Surv. Ophthalmol, 2004, 49, 491-508
13. Dunlap, J.C. Molecular bases for circadian clocks. Cell, 1999, 96, 271-290
14. Shearman, L.P.; Sriram, S.; Weaver, D. R.; Maywood, E. S.; Chaves, I.; Zheng, B.; Kume, K.; Lee, C.C.; van der Horst, G. T.; Hastings, M. H.; Reppert, S. M. Interacting molecular loops in the mammalian circadian clock. Science., 2000, 288, 1013-1019
15. Maronde, E.; Stehle, J.H. The mammalian pineal gland: known facts, unknown facets. Trends Endocrinol Metab., 2007, 18, 142-149
16. Aronson, B.D.; Bell Pedersen, D.; Block, G.D.; Bos, N.P.; Dunlap, J.C.; Eskin, A.; Garceau, N.Y.; Geusz, M.E.; Johnson, K. A.; Khalsa, S. B. Circadian rhythms. Brain Res. Brain Res.Rev., 1993, 18, 315-333
17. Lamberg, L. Chronotherapeutics: implications for drug therapy. Am. Pharm., 1991, 31, 20-23
18. Ura, J.; Shirachi, D.; Ferrill, M. The chronotherapeutic approach to pharmaceutical treatment. California Pharmacis.t, 1992, 23, 46-53
19. Desai, V. G.; Moland, C. L.; Branham, W. S.; Delongchamp, R. R.; Fang, H.; Duffy, P. H.; Peterson, C.A.; Beggs, M. L.; Fuscoe, J. C. Changes in expression level of genes as a function of time of day in the liver of rats. Mutat. Res., 2004, 549, 115-129
20. Turek, F. W.; Allanda, R. Liver has rhythm. Hepatology, 2002, 35, 743-745
21. Reinberg, A. E. Concepts of circadian chronopharmacology. Temporal control of drug delivery. New York. Ann. NY Acad. Sci., 1991, 618, 102-115
22. Lemmer, B. The clinical relevance of chronopharmacology in therapeutics. Pharmacol. Res., 1996, 33, 107-115
23. Lemmer, B. Clinical chronopharmacology: the importance of time in drug treatment. Ciba Found Symp., 1995, 183, 235-247
24. Redfern, P. Chronotherapeutics. Pharmaceutical Press: London, 2003
25. Youan, C.B. Chronopharmaceutics:gimmick or clinically relevant approach to drug delivery? J. Control. Release, 2004, 98, 337-353
26. Rani Shobha, R. H.; Pharma. review, Kongposh publication. http://www.kppub.com/articles/roadmap-clinical-research-india- 2/populationpharmacokinetics-An-overview [Accesed Oct 12, 2010]
27. Bruguolle, B.; Lemmer, B. Recent advances in chronopharmacokinetics: methodological problems. Life Sci., 1993, 52, 1809-1824
28. Lemmer, B. Chronopharmacology and controlled drug release. Expert. Opin. Drug Deliv., 2005, 2, 667-681
29. Smolensky, M.H.; Labreque, G. Chronotherapeutics. Pharm. News, 1997, 4, 10-16
30. Nave, R.; Meyer, W.; Fuhst, R.; Zech, K. Formation of fatty acid conjugates of ciclesonide active metabolite in the rat lung after 4- week inhalation of ciclesonide. Pulm. Pharmacol. Ther., 2005, 18, 390-396
31. Buhl, R.; Vinkler, I.; Magyar, P.; Gyori, Z.; Rybacki, C.; Middle, M.V.; Escher, A.; Engelstatter R. Comparable efficacy of ciclesonide once daily versus fluticasone propionate twice daily in asthma. Pulm. Pharmacol. Ther., 2006, 19, 404-412
32. Adachi, M.; Ishihara, K.; Inoue, H.; Kudo, K.; Takahashi, K.; Morita, Y.; Masuda, K.; Sakai, T.; Kato, R.; Miyamoto, T. Efficacy and safety of inhaled ciclesonide compared with chlorofluorocarbon beclomethasone dipropionate in adults with moderate to severe persistent asthma. Respirology, 2007, 12, 573-580
33. Kraft, M.; Martin, R. J. Chronobiology and chronotherapy in medicine. Disease-a-month, 1995, 41, 506-575
34. Skloot, G. S. Nocturnal asthma: mechanisms and management. Mt. Sinai J. Med., 2002, 69, 140-147
35. Washington, N.; Wilson, C.G. Can oral controlled drug delivery meet the challenges posed by chronotherapeutics? Drug Deliv. Technol., 2006, 6, 1-5
36. Haus E.; Halberg, F.; Pauly, J. E.; Cardoso, S.; Kuhl, J. S.; Sothern, R.B.; Shiotsuka, R. N.; Hwang, D. S. Increased tolerance of leukemic mice to arabinosyl cytosine with schedule adjusted to circadian system. Science, 1972, 177, 80-82
37. Evans, R.M.; Marain, C. Taking your medication: A question of timing. Am. Med. Assoc., 1996, 3-8
38. Kochman, E.; Kwarecki, K. Circadian rhythms of glucose, triiodothyronine and insulin in relation to composition of diet and mealtiming in rats. Acta. Physiol. Pol., 1984, 35, 265-275
39. Lesault, A.; Elchinger, B.; Desbals, B. Circadian rhythms of food intake, plasma glucose and insulin levels in fed and fasted rabbits. Horm. Metab. Res., 1991, 23, 515-516
40. Feuers, R. J.; Hunters, J. D.; Tsai, T. H.; Cardoso, S. S.; Scheving, L. E. Circadian stage dependent 125I-insulin binding in the liver and epididymal fat of the mouse. Prog. Clin. Biol. Res., 1990, 341, 529-534
41. Thurow, H.; Geisen, K. Stabilization of dissolved proteins against denaturation at hydrophobic interfaces. Diabetologia, 1984, 27, 212-218
42. Scheen, A. J.; Van Cauter, E. The roles of time of day and sleep quality in modulating glucose regulation: clinical implication. Horm. Res., 1998, 49, 191-201
43. Levi, F. Circadian chronotherapy for human cancers, Lancet Oncol., 2001, 2, 307-315
44. Leslie, S. The Contin delivery system: dosing considerations. J. Allergy Clin. Immunol., 1986, 78, 768-773
45. Arkinstall, W.W. Review of the North American experience with evening administration of Uniphyl tablets a once-daily theophylline preparation in the treatment of nocturnal asthma. Am. J. Med., 1988, 85, 60-63
46. Patel, G.C.; Patel, J.K.; Patel, M.M. Specialized chronotherapeutic drug delivery systems, Pharmainfo.net. Published January 30, 2007 [Accessed 13 April, 2007]
47. Sangalli, M.E.; Maroni, A.; Foppoli, A.; Zema, L.; Giordano, F.; Gazzaniga, A. Different HPMC viscosity grades as coating agents for an oral time and/or site-controlled delivery system: A study on process parameters and in vitro performances. Eur. J. Pharm. Sci., 2004, 22, 469-476
48. Sangalli, M.E.; Maroni, A.; Zema, L.; Busetti, C.; Giordano, F.; Gazzaniga, A. In vitro and in vivo evaluation of an oral system for time and/or site-specific drug delivery. J. Control Release., 2001, 73, 103-110
49. Gazzaniga, A.; Sangalli, M.E.; Giordano, F.; Minghettin, P.; Montanari, L. A new oral system for time and/or site release specificity (Chronotropic® drug delivery system). Pharmacol. Res., 1995, 31, 315
50. Gazzaniga, A.; Lamartino, P.; Maffione, G.; Sangalli, M.E. Oral delayed-release system for colonic specific delivery. Int. J. Pharm., 1994, 108, 77-78
51. Shweta, A.; Ali, J.; Alka, A.; Sanjula, B.; Qureshi, J. Pulsatile drug delivery systems: An approach for controlled drug delivery. Indian J. Pharm. Sci., 2006, 68, 295-300
52. Gazzaniga, A.; Palugan, L.; Foppoli, A.; Sangalli, M.E. Oral pulsatile delivery systems based on swellable hydrophilic polymers. Eur. J. Pharm. Biopharm., 2008, 68, 11-18
53. Ross, A.C.; MacRae, R.J.; Walther, M.; Stevens, H.N. Chronopharmaceutical drug delivery from a pulsatile capsule device based on programmable erosion. J. Pharm. Pharmacol., 2000, 52, 903-909
54. Anal, A.K. Time-controlled pulsatile delivery systems for bioactive compounds. Recent Pat. Drug Deliv. Formul., 2007, 1, 73-79
55. Verma, K.V.; Garg, S. Current status of drug delivery technologies and future directions. Pharmaceut. Technol. On-Line, 2001, 25, 1-14
56. Shiva, K.H.N.; Suresh, S.; Desai, B.G. Design and evaluation of pH sensitive multi-particulate systems for chronotherapeutic delivery of diltiazem hydrochloride. Indian J. Pharm. Sci., 2006, 68, 781-787
57. Kelly, M.L.; Tobyn, M.J.; Staniforth, J.N. Influence of processing variables on physical properties of TIMERx. Eur. J. Pharm. Sci., 1996, 4, 184
58. Kendall, M.J.; John, V.A.; Quarterman, C.P.; Welling, P.G. A single and multiple dose pharmacokinetic and pharmacodynamic comparison of conventional and slow-release metoprolol. Eur. J. Clin. Pharmacol., 1980, 17, 87-92
59. Smith, D.H.G. Pharmacology of cardiovascular chronotherapeutic agents. Am. J. Hypertension, 2001, 14, 296-301
60. Prisant, L.M.; Devane, J.G.; Butler, J. A steady-state evaluation of the bioavailability of chronotherapeutic oral drug absorption system verapamil PM after night time dosing versus immediate-acting verapamil dosed every eight hours. Am. J. Ther., 2000, 7, 345-351
61. Phillip, J. P.; Krishna, S.V.; Gopi, M. V. Timed, Sustained Release Systems For Propranolol. U.S. Patent 6,500,454, December 31, 2002
62. Srikanth, M.V.; Sharma, G.S.; Uhumwangho, M.U.; Phani Kumar, KS.; Ramana Murthy, K.V. Recent trends in pulsatile drug delivery systems - A review. Int. J. Drug Deliv., 2010, 2,200-212
63. Li B.; Zhu J.; Zheng, C.; Gong, W. A novel system for three-pulse drug release based on "tablets in capsule" device. Int. J. Pharm., 2008, 352, 159-164
64. Efentakis, M.; Koligliati, S.; Vlachou, M. Design and evaluation of a dry coated drug delivery system with an impermeable cup, swellable top layer and pulsatile release. Int. J. Pharm., 2006, 311, 147-156
65. Lee, B.J.; Ryu, S.G.; Cui, J.H. Controlled release of dual drugloaded hydroxypropyl methylcellulose matrix tablet using drug containing polymeric coatings. Int.J. Pharm., 1999, 188, 71-80
66. Karavas, E.; Georgarakis, E.; Bkikiaris, D. Felodipine nanodispersions as active core for predictable pulsatile chronotherapeutics using PVP/HPMC blends as coating layer. Int. J. Pharm., 2006, 313, 189-197
67. Maestrelli, F.; Cirri, M.; Corti, G.; Mennini, N.; Mura, P. Development of enteric coated calcium pectinate microspheres intended for colonic delivery. Eur. J. Pharm. Biopharm., 2008, 69, 508-518
68. th ACS National Meeting, San Francisco. April 13-17, 1997, p. 233
69. Dong, L. C. Drug Delivery Device With Minimal Residual Drug Retention. U.S. Patent 5,902,605, 1999
70. Wong, P.S.L. Device For Administering Active Agent To Biological Environment. U.S. Patent 5,312,388, 1995
71. Grayson, A.C. R.; Choi, I. S.; Tyler, B. M.; Wang, P.P.; Brem, H.; Cima, M.J.; Langer, R. Multipulse drug delivery from a resorbable polymeric microchip device. Nat. Mater., 2003, 2, 767-772
72. Li, Y.; Shawgo, R.S.; Tyler, B.; Henderson, P.T.; Vogel, J.S.; Rosenberg, A.; Storm, P.B.; Langer, R.; Brem, H.; Cima, M.J. In vivo release from a drug delivery MEMS device. J. Control. Release, 2004, 100, 211-219
73. Li, Y.; Ho Duc, H.L.; Tyler, B.; Williams, T.; Tupper, M.; Langer, R.; Brem, H.; Cima, M.J. In vivo delivery of BCNU from a MEMS device to a tumor model. J. Control. Release, 2005, 106, 138-145
74. Santini, J.T. Jr.; Cima, M.J.; Langer, R. A controlled-release microchip. Nature, 1999, 397, 335-338
75. John, T. S.; Michael, J. C.; Robert, S. L. Microchip Drug Delivery Devices. U.S. Patent 5,797,898, August 25, 1998.